The effect of heparin on fibrin clot stabilization
Rustamova, B.A.; Molchanova, L.V.; Kudriashov, B.A.
Voprosy Meditsinskoi Khimii 16(3): 290-293
1970
ISSN/ISBN: 0042-8809 PMID: 4247924 Document Number: 18508
Document emailed within 1 workday
Related Documents
Ishmukhametova, D.N.; Mozhina, A.A. 1984: Relation of the formation of the fibrin network of a blood clot to the amount of thrombin in complexes with endogenous heparin Anesteziologiia i Reanimatologiia 2: 30-34Aoki, N. 1993: Clot retraction increases clot resistance to fibrinolysis by condensing alpha 2-plasmin inhibitor crosslinked to fibrin Thrombosis and Haemostasis 70(2): 376
Sumi, H.; Takasugi, S. 1978: Effect of fibrin clot on plasma enzyme activation Nihon Seirigaku Zasshi. Journal of the Physiological Society of Japan 40(3): 59-61
Kudriashov, B.A.; Liapina, L.A.; Molchanova, L.V.; Rustamova, B.A. 1970: Nature of lytic effect of fibrinogen-heparin and thyroxine-heparin complexes on fibrin Voprosy Meditsinskoi Khimii 16(2): 161-168
Dolesobel, W. 1972: Use of new methods for studies of blood coagulation. II. Clot-sedimentation-technic for the determination of antithrombin i effect of fibrin Wiener Medizinische Wochenschrift 122(41): 585-590
Colucci, M.; Pentimone, A.; Binetti, B.M.; Cramarossa, M.; Piro, D.; Semeraro, N. 2002: Effect of heparin on TAFI-dependent inhibition of fibrinolysis: relative importance of TAFIa generated by clot-bound and fluid phase thrombin Thrombosis and Haemostasis 88(2): 282-287
Mirshahi, M.; Azzarone, B.; Soria, J.; Mirshahi, F.; Soria, C. 1991: The role of fibroblasts in organization and degradation of a fibrin clot Journal of Laboratory and Clinical Medicine 117(4): 274-281
Davey, F.R.; Gordon, G.B.; Boral, L.I.; Gottlieb, A.J. 1976: Gamma globulin inhibition of fibrin clot formation Annals of Clinical and Laboratory Science 6(1): 72-77
Nicosia, R.F.; Tchao, R.; Leighton, J. 1983: Angiogenesis-dependent tumor spread in reinforced fibrin clot culture Cancer Research 43(5): 2159-2166
Andrew, M.; Brooker, L.; Leaker, M.; Paes, B.; Weitz, J. 1992: Fibrin clot lysis by thrombolytic agents is impaired in newborns due to a low plasminogen concentration Thrombosis and Haemostasis 68(3): 325-330
Köhle, W.; Richter, C.; Rasche, H. 1975: Relationship between fibrin stabilization and fibrinolysis Verhandlungen der Deutschen Gesellschaft für Innere Medizin 81: 1148-1149
Vorlová, Z.; Dyr, I.E. 1979: Effect of fibrin-fibrinogenolysis on the determination of the fibrinogen content and fibrin-fibrinogen degradation products (FDP) by means of the fibrin polymerization time (FPT test) Folia Haematologica 106(5-6): 967-970
Fingert, H.J.; Chen, Z.; Mizrahi, N.; Gajewski, W.H.; Bamberg, M.P.; Kradin, R.L. 1987: Rapid growth of human cancer cells in a mouse model with fibrin clot subrenal capsule assay Cancer Research 47(14): 3824-3829
Zöller, H.; Fromme, K.; Gross, W. 1974: Hyperlipoproteinemia and fibrin stabilization using blood factor 13 Die Medizinische Welt 33(34): 1303-1304
Mikhalev, V.V. 1971: Blood coagulation and the physico-chemical properties of the fibrin-thrombocytic structure of the clot in patients with post-infarct cardiosclerosis Terapevticheskii Arkhiv 43(8): 99-102
Chang, J.C. 1987: White clot syndrome associated with heparin-induced thrombocytopenia: a review of 23 cases Heart and Lung: the Journal of Critical Care 16(4): 403-407
Carr, M.E.; Carr, S.L.; Greilich, P.E. 1996: Heparin ablates force development during platelet mediated clot retraction Thrombosis and Haemostasis 75(4): 674-678
Schoch, J.P.; Ramboatiana, R.; Runser, C. 1986: Gravely reduced thrombocyte count induced by heparin or the white clot syndrome Cahiers d'Anesthesiologie 34(5): 415-420
Kurokawa, T.; Iwasa, S.; Kakinuma, A.; Stassen, J.M.; Lijnen, H.R.; Collen, D. 1991: Enhancement of clot lysis in vitro and in vivo with a bispecific monoclonal antibody directed against human fibrin and against urokinase-type plasminogen activator Thrombosis and Haemostasis 66(6): 684-693
Itoh, J.; Nakagawa, H.; Sasaki, H.; Takahashi, T. 1985: A fibrin clot containing of anticancer drug for intra-arterial chemo-embolization therapy. (2) Chemotherapeutic effects on a model hepatoma using VX-2 carcinoma in rabbits Gan to Kagaku Ryoho. Cancer and ChemoTherapy 12(2): 258-264